Prolacta
City Of Industry, US · Delaware corporation · 5 known investors
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units. The company's products are used to support nutrition and reduce complications in extremely premature infants globally.
Founders & leadership
SE
Scott ElsterExecutive Officer, Director
FF
Frank FosterDirector
MS
Martin SutterDirector
JB
John Bacich, Jr.Director
ES
Ernie StrapazonDirector
NB
Ned BrownDirector
SC
Sally CrawfordDirector
DB
David BrailerDirector
DJ
Dan JanneyDirector
JM
John M. ShieldsExecutive Officer
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$8.9MraisedMay 2018 · 11 investors · BiotechnologyRule 506(b)
▶$8.9MraisedMay 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John ShieldsExecutive Officer
- David BrailerDirector
- Mark HannonExecutive Officer
- Victoria NiklasExecutive Officer
- Ernie StrapazonDirector
- Frank FosterDirector
- John Bacich Jr.Director
- David DreyerExecutive Officer
- Vincent GasparExecutive Officer
- Alan KofskyExecutive Officer
- Martin SutterDirector
- Scott EakerExecutive Officer
- Scott ElsterExecutive Officer, Director
- Joseph FournellExecutive Officer
- Martin LeeExecutive Officer
- Dan JanneyDirector
- Sally CrawfordDirector
- Alyson FullerExecutive Officer
- Offering amount
- $8.9M
- Amount sold
- $8.9M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35MraisedDec 2016 · 4 investors · BiotechnologyRule 506(b)
▶$35MraisedDec 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott ElsterExecutive Officer, Director
- Frank FosterDirector
- Martin SutterDirector
- John Bacich, Jr.Director
- Ernie StrapazonDirector
- Ned BrownDirector
- Sally CrawfordDirector
- David BrailerDirector
- Dan JanneyDirector
- John M. ShieldsExecutive Officer
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- The Prolacta Bioscience Foundation Empowers Parents and Communities With Over Half a Million Dollars in Grant Funding in 2022prnewswire.com · 2023
- Prolacta Bioscience(R) Raises $35 Million in Mezzanine Financingfinance.yahoo.com · 2016
- UPDATE - Prolacta Bioscience(R) Raises $35 Million in Mezzanine Financingglobenewswire.com · 2016
- Prolacta Bioscience Raises Series D funding from Health Evolution Partners - FinSMEsfinsmes.com · 2011
- Prolacta Raises $12 Million | PE Hubpehub.com · 2007